Inflarx N.V.(Ifrx) Financials: Gross Profit Margin Compared To Industry Average, Plus Other Key Ratios
Company Report for IFRX
Report - gross profit margin
This chart shows the historical trend of gross profit margin for IFRX compared to its industry average over the recent years.
Ratio Definition and Interpretation
Name: Gross Profit Margin
Definition: Gross profit margin shows how much profit the company keeps from each dollar of sales after covering the direct cost of making its products or delivering services. High margins suggest strong pricing power or efficient production. Shrinking margins might mean rising costs or tougher competition eating into profits.
Interpretation:
• In '2023', IFRX's gross profit margin was -743.7%, showing profitability after production and operational costs. Industry average for Biotechnology: Pharmaceutical Preparations in '2023' stood at 45.0%.
• In '2024', IFRX's gross profit margin was -1900.8%, showing profitability after production and operational costs. The decline from '2023' may indicate some operational or financial challenges. Industry average for Biotechnology: Pharmaceutical Preparations in '2024' stood at 60.1%. Industry average increased by 15.1% compared to previous year.
Overall, IFRX's gross profit margin has been volatile but showed a downward trend over the past 2 years.
Formula: Gross Profit Margin = (Revenue - COGS) / Revenue
Good Range: Often 20%-60% depending on industry.